<DOC>
	<DOCNO>NCT00489736</DOCNO>
	<brief_summary>The objective study compare efficacy safety dronedarone amiodarone treatment patient atrial fibrillation .</brief_summary>
	<brief_title>Efficacy &amp; Safety Dronedarone Versus Amiodarone Maintenance Sinus Rhythm Patients With Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Amiodarone</mesh_term>
	<criteria>Patients document atrial fibrillation 72 hour cardioversion antiarrhythmic treatment indicated opinion investigator oral anticoagulation Contraindication oral anticoagulation Patient receive amiodarone past whatever date ( total twenty 200 mg tablet 5 day intravenous ) Patients know chronic AF , patient atrial flutter paroxysmal atrial fibrillation Severe congestive heart failure NewYork Heart Association ( NYHA ) class III IV , severe bradycardia , high degree atrioventricular block , ongoing potentially dangerous symptom AF angina pectoris , transient ischemic attack , stroke , syncope , judge investigator , first degree family history sudden cardiac death age 50 year absence coronary heart disease , significant sinus node disease without permanent pacemaker implant History torsades de pointes long QT syndrome QT QTcinterval â‰¥500 msec randomization Treatment class I III antiarrhythmic drug discontinue Dysthyroidism contraindication amiodarone The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>sinus rhythm</keyword>
	<keyword>amiodarone</keyword>
</DOC>